Bleichroeder LP’s Cue Biopharma CUE Stock Holding History

Bleichroeder LP’s Portfolio CUE Stock Details CUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.57M	Hold	227,305	–	–	0.27%	34
2025 Q4	$2.08M	Hold	227,305	–	–	0.37%	28
2025 Q3	$4.9M	Hold	227,305	–	–	0.96%	14
2025 Q2	$4.65M	Buy	227,305 +60,730	+36%	+$1.3M	1.14%	14
2025 Q1	$4.55M	Hold	166,575	–	–	1.21%	14
2024 Q4	$5.45M	Hold	166,575	–	–	1.37%	14
2024 Q3	$3.78M	Buy	166,575 +71,188	+75%	+$1.54M	1.02%	13
2024 Q2	$3.55M	Buy	95,387 +3,553	+4%	+$176K	1.06%	17
2024 Q1	$5.21M	Buy	91,834 +33,333	+57%	+$2.35M	1.3%	18
2023 Q4	$4.63M	Buy	58,501 +33,333	+132%	+$2.38M	1.03%	16
2023 Q3	$1.74M	Hold	25,168	–	–	0.43%	24
2023 Q2	$2.76M	Hold	25,168	–	–	0.56%	25
2023 Q1	$2.7M	Sell	25,168 -3,541	-12%	-$338K	0.58%	23
2022 Q4	$2.45M	Buy	28,709 +10,209	+55%	+$934K	0.53%	27
2022 Q3	$1.24M	Hold	18,500	–	–	0.26%	36
2022 Q2	$1.38M	Buy	18,500 +100	+0.5%	+$11.7K	0.29%	36
2022 Q1	$2.69M	Buy	18,400 +11,733	+176%	+$2.49M	0.48%	34
2021 Q4	$2.26M	Buy	6,667 +834	+14%	+$323K	0.35%	42
2021 Q3	$2.55M	Hold	5,833	–	–	0.41%	41
2021 Q2	$2.04M	Buy	5,833 +3,333	+133%	+$1.29M	0.31%	44
2021 Q1	$915K	Hold	2,500	–	–	0.15%	47
2020 Q4	$938K	Sell	2,500 -2,500	-50%	-$999K	0.18%	42
2020 Q3	$2.26M	Sell	5,000 -500	-9%	-$288K	0.4%	35
2020 Q2	$4.04M	Hold	5,500	–	–	0.72%	27
2020 Q1	$2.34M	Hold	5,500	–	–	0.61%	29
2019 Q4	$2.62M	Buy	+5,500	New	+$1.73M	0.41%	27

Other funds holding CUE

GWMR

GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

AWM

Angeles Wealth Management Santa Monica, California $2.19B AUM 23.13% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Bleichroeder LP's CUE Position: Q1 2026 in Review

Bleichroeder LP held its Cue Biopharma (CUE) position steady in Q1 2026 at 227,305 shares worth $1.57M. The position accounts for 0.27% of the portfolio, ranked #34.

Bleichroeder LP first reported a position in CUE in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.45M in Q4 2024. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

Bleichroeder LP held 227,305 shares of Cue Biopharma worth $1.57M as of Q1 2026.
Bleichroeder LP left its Cue Biopharma share count unchanged in Q1 2026.
Cue Biopharma made up 0.27% of Bleichroeder LP's portfolio in Q1 2026, its #34 holding.
Bleichroeder LP first reported a position in Cue Biopharma in Q4 2019 and has held it in 26 quarters since.
Bleichroeder LP's Cue Biopharma position peaked at $5.45M in Q4 2024.
55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.